Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.54M+116%-$9.75M+9.8%-$10.81M-30.4%-$8.29M+20.1%-$10.38M-2.6%
$135K+7.1%$126K-22.7%$163K-1.2%$165K-4.1%$172K-10.9%
$2.47M+12.5%$2.2M-35.8%$3.42M+80.9%$1.89M+16.8%$1.62M-4.5%
-$6.48M-161%-$2.48M+33.0%-$3.71M+49.3%-$7.32M-62.7%-$4.5M+21.2%
$141K+244%$41K-81.0%$216K$754K+1,408%
-$141K-244%-$41K+76.7%-$176K-$714K-1,328%
$42.39M+15,201%$277K+238%$82K-99.6%$20.72M+114%$9.69M+224%
$35.76M$13.49M+201%$4.48M+262%
-$6.62M-162%-$2.53M+35.7%-$3.93M+45.7%-$7.23M-37.6%-$5.25M+8.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TriSalus Life Sciences, Inc. generate?
TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
What is TriSalus Life Sciences, Inc.'s free cash flow?
After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.